Desmopressin acetate in intracranial haemorrhage

Neurology Research International

Volumn 2014, Issue , 2014, Pages

  Kapapa, Thomas ^a   Röhrer, Stefan ^a   Struve, Sabine ^b   Petscher, Matthias ^c   König, Ralph ^a   Wirtz, Christian Rainer ^a   Woischneck, Dieter ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Klinikum Schwabing   (Germany)

^c Kreiskrankenhauses Mechernich   (Germany)

^d Klinikum Landshut   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE PHOSPHATE; ADRENALIN; DESMOPRESSIN ACETATE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BRAIN CONTUSION; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; FEMALE; HUMAN; INTENSIVE CARE; MALE; MIDDLE AGED; NEUROSURGERY; OBSERVATIONAL STUDY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; TRAUMATIC BRAIN INJURY; VERY ELDERLY;

EID: 84920520146     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2014/298767     Document Type: Article

References (29)

1. D. J. Fintel, "Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options," Vascular Health and Risk Management, vol. 8, no. 1, pp. 77-89, 2012.
2. J.-P. Bassand, "Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents," Europace, vol. 14, no. 3, pp. 312-324, 2012.
3. Federal Statistical Office of Germany, Prescibtion of Thrombocyte Aggregation Inhibitors in Germany, 2012, https://www.gbebund.de.
4. M. R. Bullock, R. Chesnut, J. Ghajar et al., "Surgical management of acute subdural hematomas," Neurosurgery, vol. 58, no. 3, pp. S216-S224, 2006.
5. M. Z. Raihan,M.H.Rashid,M. A. Syed, andM. H. Sarkar, "Factors influencing the surgical outcome of spontaneous intracerebral haematoma," Mymensingh Medical Journal, vol. 18, no. 2, pp. 245-249, 2009.
6. M. Stanisic, M. Lund-Johansen, and R. Mahesparan, "Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence," Acta Neurochirurgica, vol. 147, no. 12, pp. 1249-1256, 2005.
7. K.-M. Schebesch, C. Woertgen, R.-D. Rothoerl, O.-W. Ullrich, andA. T. Brawanski, "Cognitive decline as an important sign for an operable cause of dementia: chronic subdural haematoma," Zentralblatt für Neurochirurgie, vol. 69, no. 2, pp. 61-64, 2008.
8. G. Baldi, F. Altomonte,M. Altomonte et al., "Intracranial haemorrhage in patients on antithrombotics: Clinical presentation and determinants of outcome in a prospective multicentric study in italian emergency departments," Cerebrovascular Diseases, vol. 22, no. 4, pp. 286-293, 2006.
9. P. Saloheimo, M. Ahonen, S. Juvela, J. Pyhtinen, E.-R. Savolainen, and M.Hillbom, "Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death," Stroke, vol. 37, no. 1, pp. 129-133, 2006.
10. K.-H. Beck, P. Mohr, U. Bleckmann, H. Schweer, and V. Kretschmer, "Desmopressin effect on acetylsalicylic acid impaired platelet function," Seminars in Thrombosis and Hemostasis, vol. 21, supplement 2, pp. 32-39, 1995.
11. K. H. Beck, U. Bleckmann, P. Mohr, V. Kretschmer, and B. Huss, "Shortening of acetylsalicylic acid-prolonged bleedingtime by means of desmopressin," Beiträge zur Infusionstherapie und Transfusionsmedizin, vol. 32, pp. 437-439, 1994.
12. D. P. Sheridan, R. T. Card, J. C. Pinilla et al., "Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction," Canadian Journal of Surgery, vol. 37, no. 1, pp. 33-36, 1994.
13. P. A. Flordal and S. Sahlin, "Use of desmopressin to prevent bleeding complications in patients treated with aspirin," British Journal of Surgery, vol. 80, no. 6, pp. 723-724, 1993.
14. S. Schulman, "Pharmacologic tools to reduce bleeding in surgery," Hematology:The Education Programof the American Society of Hematology, vol. 2012, pp. 517-521, 2012.
15. S. Lethagen, "Desmopressin (DDAVP) and hemostasis," Annals of Hematology, vol. 69, no. 4, pp. 173-180, 1994.
16. F. Arzneimittel, Fachinformation MINIRIN Parenteral, 2011.
17. I. F. K. C. Universitätsklinikum-Köln, Aufbau und Funktionsweise des PFA-100, 2012, http://www.unsere-uniklinik.de/institute/ kchemie/Parameter.html.
18. R. Karger, K. Reuter, J. Rohlfs, C. Nimsky, U. Sure, and V. Kretschmer, "The platelet function analyzer (PFA-100) as a screening tool in neurosurgery," ISRN Hematology, vol. 2012, Article ID 839242, 7 pages, 2012.
19. H.Alahmadi, S. Vachhrajani, andM.D.Cusimano, "Thenatural history of brain contusion: an analysis of radiological and clinical progression: clinical article," Journal of Neurosurgery, vol. 112, no. 5, pp. 1139-1145, 2010.
20. D. Kurland, C. Hong, B. Aarabi, V. Gerzanich, and J.M. Simard, "Hemorrhagic progression of a contusion after traumatic brain injury: a review," Journal of Neurotrauma, vol. 29, no. 1, pp. 19- 31, 2012.
21. J. G. M. Van Beek, N. A. Mushkudiani, E. W. Steyerberg et al., "Prognostic value of admission laboratory parameters in traumatic brain injury: results fromthe IMPACT study," Journal of Neurotrauma, vol. 24, no. 2, pp. 315-328, 2007.
22. S. Schulz-Stübner, D. Zielske, and R. Rossaint, "Comparison between nasal and intravenous desmopressin for the treatment of aminosalicylic acid-induced platelet dysfunction," European Journal of Anaesthesiology, vol. 19, no. 9, pp. 647-651, 2002.
23. P. A. Kouides, V. R. Byams, C. S. Philipp et al., "Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid," British Journal of Haematology, vol. 145, no. 2, pp. 212-220, 2009.
24. M.C.Guth, L. Kaufner, C. Kleber, and C. vonHeymann, "Therapy of trauma-induced coagulopathy-what is the evidence?" Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, vol. 49, no. 9, pp. 528-540, 2012.
25. R. A. Reiter, F. Mayr, H. Blazicek et al., "Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin," Blood, vol. 102, no. 13, pp. 4594-4599, 2003.
26. J. S. Batchelor and A. Grayson, "A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medicationassociated intracranial haemorrhage," BMJ Open, vol. 2, no. 2, Article ID e000588, 2012.
27. G. Taylor, D. Osinski, A.Thevenin, and J.-M. Devys, "Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?" Journal of Trauma and Acute Care Surgery, vol. 74,no. 5, pp. 1367-1369, 2013.
28. C.W.Washington, D. J. E. Schuerer, and R. L. Grubb, "Platelet transfusion: an unnecessary risk formild traumatic brain injury patients on antiplatelet therapy," Journal of Trauma-Injury, Infection and Critical Care, vol. 71, no. 2, pp. 358-363, 2011.
29. P. M. Mannucci and M. Levi, "Drug therapy: prevention and treatment of major blood loss," The New England Journal of Medicine, vol. 356, no. 22, pp. 2301-2311, 2007.